Business Context and Reporting Period
This Form 8-K is a current report filed by Labstyle Innovations Corp. (not Dariohealth Corp.) on January 3, 2014, regarding an event that occurred on December 29, 2013. The company is incorporated in Delaware and maintains its principal executive offices in Caesarea Industrial Park, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
- Board Appointment: On December 29, 2013, Erez Raphael, the Company's President and Chief Executive Officer, was appointed to serve as a director on the Company's Board of Directors.
- Compensatory Arrangements: Mr. Raphael is subject to an Employment Agreement dated October 11, 2012, with amendments on April 1, 2013, and August 30, 2013. The terms of this agreement were previously disclosed in an 8-K filed on September 6, 2013.
- Related Party Transactions: Aside from the Employment Agreement, the filing states Mr. Raphael has not been involved in any other transaction requiring disclosure under Item 404(a) of Regulation S-K.
Guidance, Outlook, and Risks
The filing includes a standard cautionary note regarding forward-looking statements. It warns that actual results may differ materially from expectations due to factors such as negotiations with executives and consultants. The company explicitly states it undertakes no obligation to publicly update forward-looking statements except as required by law. No specific financial guidance or outlook is provided in this document.
Investor Verification Checklist
- Verify the correct registrant name is Labstyle Innovations Corp., not Dariohealth Corp.
- Review the Employment Agreement terms referenced in the September 6, 2013, Form 8-K to understand Mr. Raphael's compensation structure.
- Confirm the current composition of the Board of Directors following Mr. Raphael's appointment.
- Check subsequent filings for any financial data, as this 8-K contains none.